Elaine Lau, Thanuka Udumulla, Lee Izhaki-Tavor +3cs.AI
In professional life sciences workflows, scientists routinely interpret visual artifacts (gel blots, microscopy images, plasmid maps, flow cytometry plots, molecular structures, ...) to inform research decisions. We introduce VIALS, a visual question-answering benchmark with 161 such interpretation tasks, spanning the types of artifacts examined throughout experimental workflows in the biotech industry (rather than polished figures from publications and textbooks). While frontier vision-language models can now fluently describe natural images, we find that they are unable to accurately interpret these scientific images, reflecting limitations in domain knowledge and domain-specific visual reasoning capabilities. In contrast, scientists with relevant domain expertise find these visual interpretation tasks straightforward. AI that cannot similarly interpret such images will have limited utility in professional life sciences workflows, where such artifacts are central to how scientists reason, communicate, and make decisions.
Jean-Pierre Changeux, Gustavo Deco, Morten L. Kringelbachq-bio.NC cs.AI
The life sciences and health research have started to benefit from artificial intelligence, which raises ethical concerns that are real but, we argue, not special. Any science should be governed by values that rest on how the human brain is built and socialised rather than anything distinct to artificial intelligence. Importantly, the human brain has a different, much less costly computational architecture than these machines. This is achieved through the orchestration of a global neuronal workspace, and through reward best described not as a quantity to be maximised but as a continuous cycle of wanting, liking and satiety. As such, this creates the deep tension running through the ethics of the human person, between the universality of ethical judgement and the diversity of morals. The brain networks of the global workspace and emotion are universally shared, but the diversity of content is shaped by epigenetic appropriation of the particulars of the physical, social and cultural world, which makes every person unique. Still, if we were to build machines on these principles rather than the present unaffordable reward maximisers, the question of their governance would change from restraint to upbringing. We set out the institutions such a future would require, together with the questions that remain open.
Luigi Sigillo, Matteo Silvestri, Francesco Tabaro +9cs.CL cs.AI cs.IR cs.LG
The web is increasingly accessed by AI agents rather than humans. Every agent needs knowledge, especially in the life-sciences, where agentic pipelines are growing fast. Access to the literature is a crucial part of that need, and resources such as Europe PMC, with over 40M indexed records, are widely used to meet it. Yet these resources were not built for AI agents: they take keywords and complex syntax and return whole papers, so every agent must learn the syntax, issue several searches, and read full papers to find the evidence it needs. We introduce EMBL AI Librarian, a knowledge layer that upgrades the Europe PMC interface for AI agents: an agent asks in natural language and receives evidence that answers it. A single LLM orchestrates the whole knowledge retrieval process: it plans complementary subqueries executed by the live Europe PMC search engine, then reads the selected papers and locates the relevant evidence. We evaluate Librarian across four benchmarks: literature synthesis, claim verification, open-domain question answering, and downstream biology tasks such as protocol questions and sequence manipulation. On ScholarQABench, Librarian improves Citation F1 by more than $16$ points over strong recently published baselines. Used as the retrieval layer of an existing claim-verification pipeline, it increases agreement with expert consensus; and on the open-form LitQA2 benchmark, a GPT-5.4 agent scores about $8$ points higher when grounded in Librarian than with web search. Overall, our results show that equipping life-science agents with the Librarian knowledge layer improves performance across a range of tasks. We release our code publicly at https://github.com/petroni-lab/librarian
Pharmaceutical sponsors developing a drug for both the United States and the European Union must reconcile guidance issued independently by the FDA and the EMA. Where the two agencies require substantively the same thing, a sponsor can file once; where they diverge, a single trial design risks rejection in one region; where one agency is silent on a point the other regulates, the sponsor must infer obligations. Today this reconciliation is performed manually by regulatory-affairs experts. We introduce cross-jurisdiction regulatory divergence detection: given an FDA requirement and an EMA requirement on the same topic, classify their relationship as AGREE, DIVERGE, or SILENT. SILENT is inherently directional (SILENT_FDA vs. SILENT_EMA); we record direction per pair and report per-direction F1 alongside the collapsed label. We release RegDivergence-101, a 101-pair expert-grounded pilot evaluation benchmark (labels grounded in three peer-reviewed FDA/EMA comparison studies and primary FDA/EMA/ICH guidance text; dual-annotation inter-annotator kappa = 0.85), and systematically characterise a four-method baseline hierarchy: lexical heuristic (0.511 macro-F1, 95% CI [0.411-0.605]), NLI cross-encoder (0.233), obligation-level Graph-RAG (0.663 [0.570-0.747]), and flat LLM judge / Claude Haiku (0.830 [0.747-0.908]). Three directional observations emerge at pilot scale (n = 101): SILENT is semantically detectable but invisible to entailment-only formulations; pair-level obligation graphs improve over lexical methods but trail flat-LLM context (CIs partially overlapping); and corpus-level graph construction is the indicated architectural target for large-scale silent-detection. RegDivergence-101 is a pilot release establishing the task formulation and baseline hierarchy; four unrepresented regulatory domains and an expansion roadmap are described in Section 7.
Federated learning lets institutions train shared models without moving their data, which makes it a natural fit for health and life sciences research under strict privacy regulation. The methods are maturing fast, but the practical barrier now comes earlier: a team starting a federated project meets a scattered mix of frameworks, governance obligations, and unfamiliar roles, with no structured place to begin that fits its own background. FLKit closes that gap. It is an open, community-maintained onboarding toolkit that takes a multidisciplinary team through the full federated learning lifecycle and gives every contributor, clinical, legal, governance, or technical, a role-aware entry point instead of assuming fluency across all four. We modeled it on the ELIXIR Research Data Management Kit and built it with a multidisciplinary core team, a wider consortium supplying milestone reviews and roadmap direction, and external practitioners interviewed to keep the content grounded in real practice. FLKit sits on four lifecycle stages, Governance, Infrastructure, Wrangling, and Analysis, and connects them through 11 role-specific entry points, a cross-disciplinary glossary, a reusable FAIR-aligned FL Story template for planning and documenting projects, and a curated directory of tools, frameworks, and communities. Since the December 2024 demo it has grown to 39 pages across eight sections, with seven FL Stories documenting completed and ongoing projects in multiple sclerosis disability prediction, inflammatory bowel disease, genomics, and brain-computer interfaces. It is openly available at https://uhasselt-biomedicaldatasciences.github.io/federated-learning-toolkit/ and welcomes contributions from across the life sciences.